NEWS
By Knight-Ridder News Service | August 10, 1993
A new epilepsy drug, the first approved in 15 years, promises to control seizures without the harsh side effects common with more traditional treatment.Felbatol was approved last week by the U.S. Food and Drug Administration to prevent epileptic seizures in people 14 and older, or in the 10 percent of children with epilepsy who have seizures from a condition called Lennox-Gastaut syndrome, which are difficult to treat.But the drug is likely to be used, as many drugs are, for other patients, including younger children or people with mild seizures.
SPORTS
By Jamison Hensley and Jamison Hensley,SUN REPORTER | November 22, 2007
For eight weeks, Samari Rolle kept his condition a secret. "I didn't know if I could play, if I would be all right or anything," the Ravens veteran cornerback said. "It was very scary." But yesterday Rolle disclosed that he has epilepsy, a neurological condition that affects the nervous system and can cause seizures. He decided to publicly talk about his epilepsy "because it's under control now. Right now, I'm not scared." He has had three seizures this season, which have kept him out of six games.
BUSINESS
By Mark Guidera and Mark Guidera,SUN STAFF | March 28, 1997
A Maryland biotechnology company said yesterday that the Food and Drug Administration has given it tacit approval to market its new drug to treat epilepsy in the United States, one of the first new drugs to be approved for the disease in 15 years.Final regulatory approval for the drug known as Carbatrol rests on Rockville-based Shire Laboratories Inc.'s meeting certain manufacturing requirements for the drug.Krystyna Belendiuk, senior vice president for business development at Shire Laboratories -- known as Pharmavene, Inc. until it was bought recently by Shire Pharmaceuticals of Andover, England -- said the company "fully expects to meet the FDA's requests."
SPORTS
By Don Markus and Don Markus,Sun Reporter | March 11, 2008
Grace Rolle remembers the crash and the silence that followed. "You've heard of a mother's intuition?" she asked recently. "I heard a loud noise, and it sounded like somebody fell. After about two minutes, I thought that it didn't sound right. When I went downstairs to the garage, the papers were strewn everywhere." Then she saw her son, Samari, on the ground, conscious but dazed. "His lip was busted, his tongue was messed up and his neck was swollen," she said. "They have sharp, concrete stairs.
NEWS
By Christine Morris and By Christine Morris,KNIGHT RIDDER/ TRIBUNE | October 7, 2001
It was the middle of the night when Constance Hoyt awakened to find her husband, John, making anguished sounds while his arms and legs jerked around. The couple was living in Asuncion, Paraguay, where they worked in a Christian academy, and Constance Hoyt was sure she was losing her husband. Hours later, at a hospital, doctors concluded he had suffered a heart attack. A pacemaker was implanted. It was not until months later, after two more such episodes, that the Hoyts were referred to Dr. R. Eugene Ramsay at the University of Miami and learned that Hoyt, a retired pastor, had epilepsy.
HEALTH
By Meredith Cohn, The Baltimore Sun | March 5, 2012
Megan Elphage lives in fear of another big epileptic seizure. The 22-year-old Glen Burnie woman had her first seizure when she was 13. Even though medications largely keep her epilepsy under control, the prospect of seizures means she can't drive, which makes it difficult getting to classes at Anne Arundel Community College. She dreams of becoming a lawyer, but keeping a job is a challenge. She said her last employer in a retail store feared her disorder. New research on the best way to administer drugs that stop seizures could prove life-changing, as well as life-saving, for Elphage and others.